Results for this period
Interim period (second quarter)1 March 2026 to 31 August 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Increases in equipment sales for newbuildings and existing vessels for commercial shipping, maintenance services, ITS and GNSS, defense equipment, and wireless LAN projects for the education market. Sales of biochemical analyzers in healthcare declined due to intensifying cost competition in the Chinese market.
Not applicable (no matters to report in the notes on the going concern assumption)
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2026 to 31 August 2026 |
| Net Sales | ¥79,917 million (YoY +16.4%) |
| Operating profit | ¥12,866 million (YoY +38.3%) |
| Ordinary income | ¥13,781 million (YoY +35.5%) |
| Profit attributable to owners of the parent | ¥9,948 million (YoY -2.4%) |
| Net income per share | ¥314.72 |
| Equity ratio | End of the current fiscal period 65.6 / End of previous period 63.2 |
| Total assets | ¥149,553 million |
| Net assets | ¥98,546 million |
| Cash flows from operating activities | ¥6,964 million |
| Cash flows from investing activities | ¥-1,917 million |
| Cash flows from financing activities | ¥-3,188 million |
| Cash and cash equivalents at end of period | ¥25,949 million |
| Full-year earnings forecast | Net Sales ¥158,000 million (YoY +12.4%) / Operating profit ¥21,000 million (YoY +29.3%) / Ordinary income ¥22,000 million (YoY +20.3%) / Profit attributable to owners of the parent ¥17,000 million (YoY +1.6%) / Net income per share ¥537.80 |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥158,000 million / Operating profit Not disclosed → ¥21,000 million / Ordinary income Not disclosed → ¥22,000 million / Profit attributable to owners of the parent Not disclosed → ¥17,000 million |
| Annual Dividend Forecast | ¥160 → ¥210(+31.3%) |
| Segment revenue | Marine Business ¥67,794 million (YoY +13.0%), Industrial Business ¥9,342 million (YoY +34.3%), Wireless LAN and Handheld Terminal Business ¥2,643 million (YoY +69.2%), Other ¥137 million (YoY -8.5%) |
| Segment profit | Marine Business ¥12,212 million (YoY +28.3%), Industrial Business ¥822 million (YoY +339.8%), Wireless LAN and Handheld Terminal Business ¥356 million (YoY +3,520.2%), Other ¥-40 million |
| Depreciation and amortization | ¥2,037 million |
| Impairment loss | ¥26 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥24 million / Extraordinary loss Impairment Losses ¥26 million |
| Disclosure regarding the going concern assumption | Not applicable (no matters to report in the notes on the going concern assumption) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors) |
| Issued Shares at Period-End | 31,894,554 shares |
| Treasury Shares at Period-End | 282,050 shares |
| Factors Behind Changes in Business Performance | Increases in equipment sales for newbuildings and existing vessels for commercial shipping, maintenance services, ITS and GNSS, defense equipment, and wireless LAN projects for the education market. Sales of biochemical analyzers in healthcare declined due to intensifying cost competition in the Chinese market. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales of equipment for newbuildings and existing vessels for commercial shipping, maintenance services, ITS and GNSS, defense equipment, and wireless LAN projects for the education market increased. Meanwhile, sales of biochemical analyzers in the healthcare business declined due to intensifying cost competition in the Chinese market.